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INTRODUCTION
Idiopathic intracranial hypertension (IIH) is a syndrome in which intracranial pressure increases without hydrocephalus or a space oc-
cupying lesion [1-7]. It is frequently seen in young overweight women [8]. The female-male ratio varies between 2:1 and 8:1 [2, 8-10]. The age 
distribution is between 3 and 58, with the median age of 30 [11]. The incidence of the disease is 1:100 000 in the United States of America. 
This syndrome was first defined by Dandy in 1937. Later, the criteria were modified by Smith in 1985 (modified Dandy criteria), and 
updated in 2002 by Friedman and Jacobson [12, 13]. Accordingly, they are: 1) symptoms and signs of increased intracranial pressure; 
2) normal neurologic exam except 6th cranial nerve abnormalities; 3) increased cerebrospinal fluid (CSF) opening pressure (≥250 
mm H2O) but normal CSF constituency; 4) no evidence of hydrocephalus, mass, structural, or vascular lesion on imaging; 5) no other 
cause of increased ICP identified. The etiology is still obscure. Currently, three major theories are emphasized: 1) increased resis-
tance to CSF absorption, 2) increased production of CSF, 3) increased venous sinus pressure [3, 5, 6]. 
Numerous terms have been used to describe this condition (idiopathic intracranial hypertension, pseudotumor cerebri, benign 
intracranial hypertension) [12]. Currently, IIH is the most preferred, so the authors will use this term [13]. 
The symptoms of IIH are; headache, blurred vision, transient or permanent vision disorders, papilledema, diplopia, dizziness, nausea, 
hearing loss, aural fullness, and tinnitus [11, 12]. It is well known that vision disorders are due to optic nerve compression [13]. Increased 
intracranial pressure is transmitted to the optic nerve sheath via the optic canal. Raised pressure blocks the fast and slow axoplasmic 
transmission in the optic nerve axons and the result is swelling of the optic nerve fibers. With similar mechanisms, it is suggested that 
audio-vestibular symptoms are the result of vestibulocochlear nerve compression and edema following elevated intracranial pressure 
[14]. Giuseffi et al. [15] found that 58% of IIH cases complained of pulsatile tinnitus. Though Rudnick and Sismanis [16] suggested that hear-
ing loss is the result of the masking effect of tinnitus; the pathophysiologies of tinnitus and hearing loss are still unexplained. Another 
reason for the hearing loss is thought to be the transmission of raised intracranial pressure to the perilymph through the cochlear 
aqueduct [16]. By this, the tension of the basillar membrane is increased and the mobility of the stapes footplate is hindered, causing 
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OBJECTIVE: Idiopathic intracranial hypertension (IIH) can be manifested by audiological and vestibular complaints. The aim of the present study 
is to determine the audio-vestibular pathologies and their pathophysiologies in this syndrome by performing current audio-vestibular tests.
MATERIALS and METHODS: The study was performed prospectively on 40 individuals (20 IIH patients, 20 healthy volunteers). Pure tone audiom-
etry, tympanometry, vestibular evoked myogenic potentials, and electronystagmography tests were performed in both groups and the results 
were compared.
RESULTS: The mean age of both groups was found to be 30.2±18.7. There were 11 females and 9 males in each group. The study group patients 
had significantly worse hearing levels. Pure tone averages were significantly higher in both ears of the study group (p<0.05). Ten patients (50%) in 
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one (5%) control had variable abnormal VEMP records (p=0008).
CONCLUSION: Many IIH patients initially visit otolaryngology clinics since cochlear and vestibular systems are frequently affected in this condi-
tion. Our test results suggest inner ear pathologies in these patients. Higher incidence of inferior vestibular nerve and/or saccule dysfunction is 
detected as a novelty. Increased intracranial pressure may affect the inner ear with similar mechanisms as in hydrops.
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hearing loss [16]. Otorhinolaryngologists should be familiar with this 
syndrome since many patients are presented with audiological and 
vestibular symptoms. Nevertheless, there are limited studies in the lit-
erature, that investigates the audio-vestibular signs in IIH. Our aim is to 
observe the audio-vestibular effects of IIH and clarify the pathophysi-
ology, by using current audio-vestibular tests. 
MATERIALS and METHODS
Between September 2008 and June 2010, 20 IIH patients were in-
cluded in this study. IIH diagnosis was based on the modified Dandy 
criteria : 1) symptoms and signs of increased intracranial pressure; 
2) normal neurologic exam except 6th cranial nerve abnormalities; 
3) increased CSF opening pressure (≥250 mm H2O) but normal CSF 
constituency; 4) no evidence of hydrocephalus, mass, structural, or 
vascular lesion on imaging; 5) no other cause of increased ICP iden-
tified (12-14). Since this condition is rarely diagnosed, only 20 patients 
after exclusions were included in this specific period of time. Twenty 
healthy individuals constituted the control group. The criteria for es-
tablishing the study group patients were as follows: 
1) Patients who were diagnosed with IIH,  
2) IIH patients, who did not have any other neurotological patholo-
gies that may result with hearing loss, tinnitus, or vertigo, 
3) IIH patients who were not diagnosed with any other organic cere-
bral pathologies, 
4) Patients who did not have additional pathologies causing con-
ducting-type hearing loss, 
5) Patients who could easily accommodate audiometry, tympanom-
etry, electronystagmography (ENG), and vestibular evoked myogenic 
potentials (VEMP) tests.
The control group was selected among age and sex-matched healthy 
volunteers who did not have audio-vestibular pathologies. 
Groups were informed and asked to sign the clinical research volun-
teer and informed consent form. All the tests that were practiced in 
this study were evaluated and approved by the Başkent University 
Medical and Health Sciences Research Committee (Study no: KA 
08/189).
Patients and volunteers had audiometry, tympanometry, electro-
nystagmography (ENG) and vestibular evoked myogenic potentials 
(VEMP) tests [17-19].
Routine otorhinolaryngologic examination was performed initial-
ly. Audiologic evaluation was carried out under the International 
Acoustics Company (IAC) standards with “Clinic Audiometer, AC40”, 
Interacoustics Co., Assens, Denmark) and “Telephonics TDH 39P” 
ear-phone (Telephonics Co., Farmingdal, New York, U.S.A). Air and 
bone-conducting thresholds were determined between 25−8000 
Hz. and 250−2000 Hz., respectively. Acoustic impedance analysis was 
detected using “Impedance Audiometer AZ 26” (Interacoustics Co., 
Assens, Denmark).
For ENG, a “Micromedical Spectrum ENG”, (Micromedical Technologies, 
U.S.A) device was used. ENG analyzes central-peripheral vestibular and 
oculomotor system pathologies using gaze, saccadic pursuit, tracking, 
optokinetic, positional, Dix-Hallpike, and bithermal caloric tests. 
During caloric tests, the patient’s head was elevated approximate-
ly 30 degrees, in order to position the lateral semicircular canal 
in the vertical plane. Cold and warm stimuli were 30°C and 44°C 
water, respectively. The external ear canal was irrigated for at least 
30 seconds. Then, slow phase nystagmus that occurred within 2 
minutes was observed and the peak velocity was calculated. Ca-
nal paresis or directional preponderance was calculated using the 
Jonkees formula. Results higher than 20% were determined as ca-
nal paresis.
If any accompanying pathology was suspected, internal acoustic ca-
nal magnetic resonance imaging (IAC-MRI) was considered. Patients 
with co-existing pathologies were disqualified. 
VEMPs were detected by using an “EP 25” (Interacoustics Co., Assens, 
Denmark) device. The patient was asked to sit straight with the neck 
rotated towards the opposite side of the ear that was stimulated. The 
active electrode was placed in the middle one-third of the sternoclei-
domastoid muscle (SCM), the reference electrode was placed above 
the sternoclavicular joint, and the ground electrode was located 
in the middle forehead. The ipsilateral SCM responses to monoau-
ral stimulus were recorded. Electromyographic (EMG) signals were 
amplified and filtered below 10 Hz and above 3000 Hz. Tone burst 
stimulus in 500 Hz was used. The stimulation period was 5 msec and 
stimulus was given for 50 msec with a velocity of 5 Hz via a “Telepho-
nics TDH-49P” earphone. The results were recorded by calculating 
the average of 128 stimuli.
During VEMP analysis, the first positive (p13) and the following neg-
ative (p23) wave latencies and inter-peak amplitudes were calculat-
ed. The VEMP asymmetry ratio in the study group was calculated 
using the formula: 100 (An-Ap) / (An+Ap), in which Ap is p13−p23 
amplitude in the affected ear and An is the p13−p23 amplitude in 
the normal ear. In the control group, the formula: 100 (Aright-Aleft) / 
(Aright+ Aleft) was used [17, 18].
Data were analyzed using the Statistical Package for the Social Sci-
ences (SPSS) for Windows (version 15.0; SPSS Inc.; Chicago, IL, USA). 
The Student’s t-test and the chi-square test were used for compari-
sons between the groups (Fisher’s exact test was used if the expected 
cell count in one or more cells was less than 5). Statistical significance 
was defined with p values less than 0.05.
RESULTS
The mean age was 30.2±18.7. There were 11 females and 9 males in 
each group. The mean BMIs of both the study and control groups 
were 25.4+5.84 and 23.5+4.93 respectively (p>0.211) (Table 1). The 
symptoms for IIH were; dizziness (40%, n=8), tinnitus (15%, n=3), 
hearing loss (30%, n=6), pressure sensation (5%, n=1), and aural 
fullness (5%, n=1). Among these, the hearing loss was significantly 
higher (p=0.01). Seven patients (35%) were medically treated [5 with 
Diazomid (Asetazolamide; Sanofi Aventis, İstanbul, Turkey), 1 with 
steroids, and 1 with Keppra (Levetiracetam; UCB Pharmaceuticals 
Inc.; Brussels, Belgium)]. Nine patients (45%) had lumboperitoneal 
shunt. The control group consisted healthy volunteers, while in 4 
study patients, co-morbidities [hypertension (n=2), diabetes mellitus 
(n=1), and lymphoblastic leukemia (n=2)] were detected (p=0.196) 
(Table 1).
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The study patients had significantly worse hearing levels (in the right 
ear, at: 250, 500, and 1000 Hz., (p=0.001); in the left ear at: 1000 and 
2000 Hz., (p=0.007 and p=0.046). Pure tone averages were signifi-
cantly higher in both ears of the study group (p<0.05). The speech 
discrimination scores were insignificant (p>0.05) (Figure 1).
According to tympanometry results, 3 patients (15%) in the study 
group had no reflexes while all the healthy subjects had acoustic re-
flexes (p>0.05). The median values of impedancemetry in right and 
left ears of the study group were -20 (-31.5−-13) daPa and -22 (-31−-
16) daPa, respectively. In the control group, the results for right and 
left ears were -20 (-27.25−-12) daPa, and -16 (-27—10.5) daPa, respec-
tively (p>0.05).
Ten patients (50%) (saccadic latency prolongation in 4, optokinetic 
test asymmetry in 5, and tracking test abnormalities in 2 patients) 
in the study group and one healthy volunteer (5%) (saccadic latency 
prolongation) had signs in ENG, possibly related to central patholo-
gies (p=0.008). Among the subtests, only the optokinetic test results 
were significant (p=0.024). Three patients (15%) had abnormal posi-
tional test results (p>0.05).
Three patients (15%) (2 in the left ear, 1 in the right ear) and 1 (5%) 
volunteer (left ear) had canal paresis (p>0.05). There was directional 
preponderance in 1 (5%) patient and in 2 (10%) control individuals 
(p>0.05). The caloric test results for each ear in each group were sta-
tistically insignificant (p>0.05) (Figure 2).
Eight (40%) patients had variable pathological signs in the VEMP 
[2 (10%) patients with latency prolongation, 1 (5%) patient with 
increased amplitude, and 1 (5%) patient with decreased ampli-
tude in the right ear; 1 (5%) patient with increased amplitude 
and 2 (10%) patients with decreased amplitude in the left ear]. 
Three patients lacked VEMP responses, with one of them bilat-
erally). Pathological test results were marked in the right ear of 
three (15%) and in the left ear of six (30%) patients. Only one (5%) 
in the control group showed VEMP abnormalities in the left ear 
(p=0.008). Interaural differences in both groups were insignificant 
(p=0.478).
DISCUSSION
A significant number of IIH patients attend clinics with audio-vestib-
ular symptoms and the audiometry, ENG, and VEMP tests showed 
significant abnormalities in these patients. 
In this study, BMI values were insignificant. The patients were under 
various treatments during the study including weight loss programs, 
which as a result might have altered the values. 
In 1981, Sismanis [19] analyzed a patient with pulsatile tinnitus, in 
whom, bilateral papilledema and increased CSF pressure was ob-
served. After lumbar puncture, the patient had a temporary relief 
from symptoms. 
In the study of Saxena et al. [19, 20, 21], including 63 patients with in-
creased intracranial pressure, 38% of patients had hearing loss, 21.3% 
had tinnitus, and 11% had vertigo complaints In 1943, Fisher and 
Wolfson [22] observed continuous or intermittent tinnitus, high fre-
quency hearing loss, vertigo, spontaneous nystagmus, and bilateral 
labyrinth hyper-reaction in their patients.
Kaaber and Zilstorff [23] investigated audio-vestibular signs in 34 IIH 
patients in 1978. They observed tinnitus complaints in 4, bilateral 
hearing loss in 1, and vertigo in 2 patients. 
According to our study, similarly, patients attended to our clinic 
especially with hearing loss, dizziness/vertigo, or pressure sense in 
Table 1. Characteristics and symptoms of the patient and control groups
 Patients (n=20) Control (n=20) p
Age 30.2±18.7 30.2±18.7 1.00
Sex (F/M) 11/9 11/9 1.00
BMI 25.4±5.84 23.5±4.93 0.211
Dizziness-vertigo 8 (40%) 0 (0%) 0.002
Tinnitus 3 (15%) 0 (0%) 0.115
Hearing loss 6 (30%) 0 (0%) 0.01
Pressure sense 1 (5%) 0 (0%) 0.005
Fullness 1(5%) 0 (0%) 0.500
Vision disorders 0 (0%) 0 (0%) Not calculated
Medical therapy 7 (35%) 0 (0%) 0.037
Operation 9 (45%) 0 (0%) 0.001
Systemic disease 4 (20%) 0 (0%) 0.196
BMI; body mass index
Figure 1. Comparing hearing levels at each frequency in both idiopathic intra-
cranial hypertension (IIH) and control groups. For the right ear, hearing levels 
at 250, 500, and 1000 Hz; for the left ear hearing, levels at 1000 and 2000 Hz 
(p<0.05).
25
20
15
10
5
0
R L R L R L R L R L R L
250 Hz 500 Hz 1000 Hz 2000 Hz 4000 Hz 8000Hz
Frequencies
H
ea
rin
g 
le
ve
l (
de
ci
be
l)
IIH
Control
Figure 2. The caloric responses of right and left ears in both groups (p>0.05).
35
30
25
20
15
10
5
0
Cal R wam Cal L wam Cal R cold Cal L cold
IIH
Control
102
J Int Adv Otol 2017; 13(1): 100-4
the ears. Lumboperitoneal shunt procedures and medications in 
use during the otolaryngologic examinations might have relieved 
the initial audio-vestibular symptoms. Thus the authors believe that 
symptoms could have been more severe at initial neuro-otologic ex-
aminations. 
Sismanis [19] studied 20 female IIH patients between the years 1981 
and 1985. Pure tone audiometry, tympanometry, and ENG tests were 
performed. Hearing loss, especially in low frequencies, was observed 
(250, 500 Hz). After improvement of the intracranial pressure levels, 
hearing loss in the affected frequencies recovered. These results co-
here with our study results.
In our study, hearing loss was observed in 250, 500, and 1000 Hz in 
the right ear; and in 1000 and 2000 Hz in the left ear. Varying hear-
ing levels in each ear and each frequency may be explained with 
further studies with a greater number of patients. Nevertheless, to 
our knowledge, the tendency of one side to inner ear pathologies 
is not mentioned in the English literature. Lower frequency hearing 
loss suggests a similar mechanism as in the endolymphatic hydrops. 
This current study differs from the studies of Saxena et al. [20] and Tan-
don et al. [21] because only sensorineural hearing loss was observed. 
Saxena et al. [20, 21] studied 65 IIH patients and 81% had hearing loss. 
Among them, 77.5% had sensorineural hearing loss, and 22.5% had 
conductive type hearing loss. Conductive type hearing loss was de-
termined as a result of the higher incidence of otosclerosis in the 
study group. During the study design, we excluded patients with 
co-morbid ear pathologies causing conductive hearing loss, which 
may be why we did not observe any such hearing loss.
Speech discrimination scores and tympanometry results were similar 
in both groups in our study, and the results match the literature [19]. 
Static compliances were not compared in this study. 
Kaaber and Zilstorff [23] evaluated the vestibular functions of 34 IIH 
patients with ENG. Affected vestibular functions were seen in 19 pa-
tients; 9 patients had a decreased caloric response, 9 patients had 
directional preponderancy, and hyperreactivity was detected in one 
patient. Though they could not find any significant relationship be-
tween peripheral vestibular functions and intracranial pressure, they 
observed that, during the follow-up, vestibular functions were im-
proved as the pressure was normalized.
We found significantly higher abnormal ENG results in the study 
group, but there were no significant pathologic signs in positional 
and caloric tests. ENG showed abnormal responses indicating central 
dysfunction in our study group. This syndrome primarily affects the 
central nervous system and neurologic findings are indispensable. 
Three patients showed abnormal positional tests, raising the possi-
bility of co-existing BPPV. All the study group patients were selected 
from patients that were free of other central or peripheral vestibular 
pathologies. Increased intracranial pressure, and so inner ear pres-
sure alterations, may affect the utricule and saccule, leading to oto-
lith dysfunctions nonetheless.
According to our results so far, it is observed that both cochlear and 
vestibular organs are primarily affected in this syndrome. The trans-
mission of increased cerebrospinal pressure to the cochlear aque-
duct and internal acoustic canal, causing compression or increased 
tension in the cochleovestibular nerve or endolymphatic system, is 
one of the main pathophysiological explanations [21]. Another possi-
ble mechanism for the vestibular symptoms may be endolymphatic 
fluid malabsorption as a result of direct compression or decreased 
vascular supply of the the endolymphatic sac that is wrapped in be-
tween both dural leaflets [21]. 
To our knowledge, no study in the literature considered the inferior 
vestibular nerve and saccule functions using a VEMP test, in IIH pa-
tients. The VEMP responses in our study were significantly abnormal. 
Abnormal VEMP test results included: increased or decreased ampli-
tude, prolonged latency, and absence of VEMP responses. The results 
suggested that increased intracranial pressure may affect the inferior 
vestibular nerve and/or saccule. The saccule is in the membranous 
labyrinth, filled with endolymph, and is located in the bony labyrinth 
filled with perilymph [24]. The endolymphatic sac responsible for the 
absorption of endolymph, is connected to the utricule and the sac-
cule via the endolymphatic canal [25]. Pressure alterations in each lo-
cation are directly or indirectly transmitted to others. 
The saccule is the second most common site of involvement in en-
dolymphatic hydrops [24, 26-28]. It is suggested that increased endolym-
phatic pressure dilates the saccular maculae, which results in delayed 
VEMP responses [28, 29]. It is known that, especially, decreased ampli-
tude or no response in VEMP may be associated with endolymphat-
ic hydrops [29, 30]. Additionally, central pathologies may also change 
VEMP responses [30]. Our results in VEMP were: increased amplitude, 
decreased amplitude, prolonged latencies, or absence of responses. 
The results are promising; however, the efficacy, sensitivity, and spec-
ificity of VEMP in IIH needs further study. Comprehensive interpreta-
tions of the results and their clinical significance need to be clarified 
with additional studies. 
During the time of testing, intracranial hypertension status of many 
patients was unclear since many had had undergone previous treat-
ment for their disorder. However, significant pathological findings 
were seen in the audiometry, ENG, and VEMP tests, which may sup-
port the hypothesis that raised intracranial pressure affects both co-
chlear and vestibular end organs and/or the audio-vestibular nerves. 
Additionally, VEMP results showed that the inferior vestibular nerve 
may be directly or indirectly (due to saccular dysfunction) affected 
due to the increased intracranial pressure. 
CONCLUSION
Elevated intracranial pressure may induce perilymphatic and endo-
lymphatic pressure alterations, causing audio-vestibular complaints. 
The mechanisms seem to be similar as in the hydrops. The challenge 
of this study include: having a small study group, being unable to 
examine some of these patients initially, their medical and surgical 
therapies, and working on a syndrome demonstrating both central 
and peripheral vestibular signs. Even so, this clinical research is the 
first study to search for audio-vestibular signs using all the current 
audio-vestibular tests including VEMP. Previously, hearing abnormal-
ities in IIH were mentioned in the literature; but vestibular dysfunc-
tions related with this syndrome comprise a novel research area. In 
light of IIH, otorhinolaryngologists can consider this syndrome in pa-
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tients with audio-vestibular complaints and other departments may 
consult more frequently with otorhinolaryngology clinics during 
the diagnostic evaluations. Thus, further studies with an  increased 
number of patients attending as soon as their symptoms begin may 
be handled. Static compliance differences, and electrocochleograph-
ic, VEMP (both cervical and ocular) measurements may be future 
achievements.
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